Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, The Netherlands; The D-Lab: Decision Support for Precision Medicine, GROW - School for Oncology & MCCC, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Radiation Oncology (MAASTRO), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, The Netherlands.
Radiother Oncol. 2017 Dec;125(3):379-384. doi: 10.1016/j.radonc.2017.09.041. Epub 2017 Nov 6.
We aimed to identify tumour subregions with characteristic phenotypes based on pre-treatment multi-parametric functional imaging and correlate these subregions to treatment outcome. The subregions were created using imaging of metabolic activity (FDG-PET/CT), hypoxia (HX4-PET/CT) and tumour vasculature (DCE-CT).
36 non-small cell lung cancer (NSCLC) patients underwent functional imaging prior to radical radiotherapy. Kinetic analysis was performed on DCE-CT scans to acquire blood flow (BF) and volume (BV) maps. HX4-PET/CT and DCE-CT scans were non-rigidly co-registered to the planning FDG-PET/CT. Two clustering steps were performed on multi-parametric images: first to segment each tumour into homogeneous subregions (i.e. supervoxels) and second to group the supervoxels of all tumours into phenotypic clusters. Patients were split based on the absolute or relative volume of supervoxels in each cluster; overall survival was compared using a log-rank test.
Unsupervised clustering of supervoxels yielded four independent clusters. One cluster (high hypoxia, high FDG, intermediate BF/BV) related to a high-risk tumour type: patients assigned to this cluster had significantly worse survival compared to patients not in this cluster (p = 0.035).
We designed a subregional analysis for multi-parametric imaging in NSCLC, and showed the potential of subregion classification as a biomarker for prognosis. This methodology allows for a comprehensive data-driven analysis of multi-parametric functional images.
我们旨在根据治疗前的多参数功能成像来识别具有特征表型的肿瘤亚区,并将这些亚区与治疗结果相关联。这些亚区是通过代谢活性(FDG-PET/CT)、缺氧(HX4-PET/CT)和肿瘤血管生成(DCE-CT)成像创建的。
36 例非小细胞肺癌(NSCLC)患者在根治性放疗前接受了功能成像。对 DCE-CT 扫描进行动力学分析,以获取血流(BF)和体积(BV)图。HX4-PET/CT 和 DCE-CT 扫描与计划 FDG-PET/CT 进行非刚性配准。对多参数图像进行了两次聚类步骤:首先将每个肿瘤分割成同质的亚区(即超体素),其次将所有肿瘤的超体素分组为表型聚类。根据每个聚类中超体素的绝对或相对体积对患者进行分组;使用对数秩检验比较总生存期。
无监督的超体素聚类产生了四个独立的聚类。一个聚类(高缺氧、高 FDG、中 BF/BV)与高危肿瘤类型相关:被分配到该聚类的患者与未被分配到该聚类的患者相比,生存情况显著更差(p=0.035)。
我们为 NSCLC 的多参数成像设计了一个亚区分析,并显示了亚区分类作为预后生物标志物的潜力。该方法允许对多参数功能图像进行全面的数据驱动分析。